AG
DTIL icon

Algert Global’s Precision BioSciences DTIL Stock Holding History

Algert Global’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
+28,730
New +$202K ﹤0.01% 1174
2020
Q1 		– Sell
-911
Closed -$380K – 437
2019
Q4 		$380K Buy
+911
New +$286K 0.11% 238

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Algert Global's DTIL Position: Q2 2026 in Review

Algert Global opened a new position in Precision BioSciences (DTIL) in Q2 2026: 28,730 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #1174 among its holdings. This is a return to the name: Algert Global previously reported a position in DTIL as recently as Q4 2019.

Algert Global first reported a position in DTIL in Q4 2019 and has held it in 2 quarters since. The position peaked at $380K in Q4 2019. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Algert Global held 28,730 shares of Precision BioSciences worth $226K as of Q2 2026.
  • Precision BioSciences was a new Algert Global position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Algert Global's portfolio in Q2 2026, its #1174 holding.
  • Algert Global first reported a position in Precision BioSciences in Q4 2019 and has held it in 2 quarters since.
  • Algert Global's Precision BioSciences position peaked at $380K in Q4 2019.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.